According to the data obtained from the Human Protein Atlas database [7], a high intensity staining the tumor cells with anti-HAVcr-1 polyclonal antibodies was detected in breast and stomach cancer, a weak or moderate intensity was revealed in colon cancer, pancreas, non-small cell lung cancer, and ovarian carcinoma. This evidence concerns the gene HAVCR1 and neoplasm.